Published in Allergy Asthma Proc on March 29, 2007
Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines (2012) 1.04
Systemic and mucosal immune responses to sublingual or intramuscular human papilloma virus antigens in healthy female volunteers. PLoS One (2012) 1.01
Specific immunotherapy in combination with Clostridium butyricum inhibits allergic inflammation in the mouse intestine. Sci Rep (2015) 0.96
Subsets of regulatory T cells and their roles in allergy. J Transl Med (2014) 0.85
The transcriptome of a complete episode of acute otitis media. BMC Genomics (2015) 0.82
Production of recombinant allergens in plants. Phytochem Rev (2008) 0.80
Critical appraisal of Timothy grass pollen extract GRAZAX(®) in the management of allergic rhinitis. Drug Des Devel Ther (2015) 0.75
Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes". Blood (2008) 2.50
Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol (2004) 2.15
Glycopyrronium bromide for the treatment of chronic obstructive pulmonary disease. Expert Rev Respir Med (2014) 1.97
Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells. J Clin Oncol (2005) 1.30
Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol (2012) 1.29
Shrinking the room for invasive ventilation in hypercapnic respiratory failure. Int J Chron Obstruct Pulmon Dis (2013) 1.20
Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells. J Immunol (2009) 1.14
Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber. J Allergy Clin Immunol (2009) 1.13
Effect of noninvasive mechanical ventilation in elderly patients with hypercapnic acute-on-chronic respiratory failure and a do-not-intubate order. Int J Chron Obstruct Pulmon Dis (2008) 1.09
Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers. J Immunol (2008) 1.08
Bridging allergologic and botanical knowledge in seasonal allergy: a role for phenology. Ann Allergy Asthma Immunol (2010) 1.04
Production and proteomic characterization of pharmaceutical-grade Dermatophagoides pteronyssinus and Dermatophagoides farinae extracts for allergy vaccines. Int Arch Allergy Immunol (2006) 1.03
Polysensitization as a challenge for the allergist: the suggestions provided by the Polysensitization Impact on Allergen Immunotherapy studies. Expert Opin Biol Ther (2011) 1.00
IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int Arch Allergy Immunol (2007) 1.00
Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells. J Allergy Clin Immunol (2008) 1.00
Quality control of house dust mite extracts for allergen immunotherapy. Int Arch Allergy Immunol (2013) 0.99
Efficacy of sublingual immunotherapy. JAMA (2013) 0.98
Nasal cytology in children: recent advances. Ital J Pediatr (2012) 0.97
Children's compliance with allergen immunotherapy according to administration routes. J Allergy Clin Immunol (2005) 0.96
Patient's compliance with allergen immunotherapy. Patient Prefer Adherence (2008) 0.94
Sublingual immunotherapy in children with allergic polysensitization. Allergy Asthma Proc (2010) 0.93
The clinical stage of allergic rhinitis is correlated to inflammation as detected by nasal cytology. Inflamm Allergy Drug Targets (2011) 0.92
Economic studies of immunotherapy: a review. Curr Opin Allergy Clin Immunol (2008) 0.92
Long-term survival in elderly patients with a do-not-intubate order treated with noninvasive mechanical ventilation. Int J Chron Obstruct Pulmon Dis (2011) 0.91
In vivo physiological transdifferentiation of adult adipose cells. Stem Cells (2009) 0.90
Relationship between the atopy patch test and clinical expression of the disease in children with atopic eczema/dermatitis syndrome and respiratory symptoms. Ann Allergy Asthma Immunol (2008) 0.90
Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. Ann Allergy Asthma Immunol (2005) 0.90
Patient-related factors in rhinitis and asthma: the satisfaction with allergy treatment survey. Curr Med Res Opin (2011) 0.90
Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma. Allergy Asthma Proc (2006) 0.90
Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. J Allergy Clin Immunol (2007) 0.90
A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy. J Allergy Clin Immunol (2012) 0.89
Dissecting the causes of atopic dermatitis in children: less foods, more mites. Allergol Int (2012) 0.88
Economic evaluation of 5-grass pollen tablets versus placebo in the treatment of allergic rhinitis in adults. Clin Drug Investig (2013) 0.86
House dust mite-related allergic diseases: role of skin prick test, atopy patch test, and RAST in the diagnosis of different manifestations of allergy. Eur J Pediatr (2009) 0.86
Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccine. Clin Cancer Res (2002) 0.86
Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: a number needed to treat study. Int J Chron Obstruct Pulmon Dis (2009) 0.86
Poland sequence and hyperhomocyst(e)inaemia. Prenat Diagn (2002) 0.85
Birch-apple syndrome treated with birch pollen immunotherapy. Int Arch Allergy Immunol (2011) 0.85
Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study. Curr Med Res Opin (2008) 0.85
Single cell assessment of allergen-specific T cell responses with MHC class II peptide tetramers: methodological aspects. Int Arch Allergy Immunol (2008) 0.84
Development of a sublingual allergy vaccine for grass pollinosis. Drug Des Devel Ther (2010) 0.84
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients. Cancer Gene Ther (2003) 0.84
Specific IgE response to different grass pollen allergen components in children undergoing sublingual immunotherapy. Clin Mol Allergy (2012) 0.84
Toxocariasis resulting in seeming allergy. Iran J Allergy Asthma Immunol (2009) 0.84
Seroprevalence of IgG anti-Toxocara species antibodies in a population of patients with suspected allergy. Int J Gen Med (2011) 0.83
Lack of neo-sensitization to Pen a 1 in patients treated with mite sublingual immunotherapy. Clin Mol Allergy (2010) 0.83
Immunological foundations to the quest for new vaccine adjuvants. BioDrugs (2004) 0.83
Induction of allergen-specific tolerance via mucosal routes. Curr Top Microbiol Immunol (2011) 0.82
Development of an allergen extract for sublingual immunotherapy--evaluation of Staloral. Expert Opin Biol Ther (2009) 0.82
A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency. Ital J Pediatr (2013) 0.82
Do indications to sublingual immunotherapy need to be revised? J Allergy Clin Immunol (2010) 0.82
Lactic acid bacteria as adjuvants for sublingual allergy vaccines. Vaccine (2010) 0.82
Idiopathic eosinophilic parotitis in an eight-year-old boy: a case report. J Med Case Rep (2011) 0.82
Lactococcus lactis NCC 2287 alleviates food allergic manifestations in sensitized mice by reducing IL-13 expression specifically in the ileum. Clin Dev Immunol (2011) 0.82
Expression and characterization of natural-like recombinant Der p 2 for sublingual immunotherapy. Int Arch Allergy Immunol (2012) 0.81
Bifidobacterium bifidum NCC 453 promotes tolerance induction in murine models of sublingual immunotherapy. Int Arch Allergy Immunol (2011) 0.81
Pulmonary rehabilitation as evaluated by clinical trials: an overview. Rev Recent Clin Trials (2010) 0.81
Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony- stimulating factor induced a tumor-specific cellular immune response. Clin Cancer Res (2003) 0.81
A synthetic triacylated pseudo-dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route. Vaccine (2007) 0.81
Sublingual immunotherapy in children: facts and needs. Ital J Pediatr (2009) 0.81
Adherence issues related to sublingual immunotherapy as perceived by allergists. Patient Prefer Adherence (2010) 0.81
A role for Waldeyer's ring in immunological response to allergens. Curr Med Res Opin (2013) 0.80
Enhanced multiepitope-based vaccines elicit CD8+ cytotoxic T cells against both immunodominant and cryptic epitopes. Vaccine (2005) 0.80
Safety of sublingual immunotherapy started during the pollen season. Curr Med Res Opin (2009) 0.80
Ranking in importance of allergen extract characteristics for sublingual immunotherapy by Italian specialists. Allergy Asthma Proc (2014) 0.80
SLIT prevents the development of eczema in percutaneous allergen-sensitized mice. J Invest Dermatol (2011) 0.80
Emerging drugs for allergic conjunctivitis. Expert Opin Emerg Drugs (2014) 0.80
Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma. Ann Allergy Asthma Immunol (2009) 0.79
Glycoproteins are species-specific markers and major IgE reactants in grass pollens. Plant Biotechnol J (2011) 0.79
Effects of sublingual immunotherapy on allergic inflammation: an update. Inflamm Allergy Drug Targets (2012) 0.79
Recombinant fusion proteins assembling Der p 1 and Der p 2 allergens from Dermatophagoides pteronyssinus. Int Arch Allergy Immunol (2010) 0.79
Exhaled nitric oxide and nasal tryptase are associated with wheeze, rhinitis and nasal allergy in primary school children. Biomarkers (2014) 0.79
The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children. J Asthma Allergy (2011) 0.79